Letrochek 2.5 Tablet
Letrozole 2.5 mg USP Tablet
Manufactured by Dr. Morepen Laboratories Ltd.
High-quality aromatase inhibitor tablet formulated for the effective management of hormone-responsive breast cancer.
Used in the treatment of postmenopausal women with hormone receptor-positive breast cancer and may be prescribed as adjuvant, extended adjuvant, or advanced-stage therapy as directed by a healthcare professional.
Convenient oral tablet formulation designed to provide reliable hormonal therapy, manufactured under strict pharmaceutical quality standards to ensure safety, efficacy, and consistency.